Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Renal Cell Carcinoma

Known as: Adenocarcinoma of the Kidney, Carcinoma, Renal Cell [Disease/Finding], rccs 
A carcinoma arising from the renal parenchyma. There is a strong correlation between cigarette smoking and the development of renal cell carcinoma… Expand
National Institutes of Health

Related topics

Related topics

49 relations
AldesleukinBlood supply aspectsCDISC SEND Tumor Findings Results TerminologyCISH gene
Expand

Broader (4)

CarcinomaKidney NeoplasmNeoplasmsRenal carcinoma

Narrower (4)

Chromophobe Renal Cell CarcinomaClear-cell metastatic renal cell carcinomaCollecting Duct Carcinoma of the KidneyThyroid Carcinoma, Papillary, With Papillary Renal Neoplasia

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
Nivolumab plus ipilimumab versus sunitinib in first-line treatment for advanced renal cell carcinoma: extended follow-up of efficacy and safety results from a randomised, controlled, phase 3 trial.
BACKGROUND In the ongoing phase 3 CheckMate 214 trial, nivolumab plus ipilimumab showed superior efficacy over sunitinib in… Expand
Review
2019
Review
2019
Combination of CTLA-4 and PD-1 blockers for treatment of cancer
  • A. Rotte
  • Journal of experimental & clinical cancer…
  • 2019
    • Corpus ID: 189817689
Targeting checkpoints of immune cell activation has been demonstrated to be the most effective approach for activation of anti… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
  • table 4
Review
2019
Review
2019
Towards individualized therapy for metastatic renal cell carcinoma
Over the past decade, the treatment landscape for patients with metastatic renal cell carcinoma (RCC) has evolved dramatically… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
Review
2019
Review
2019
Physical Activity in Cancer Prevention and Survival: A Systematic Review
Purpose This article reviews and updates the evidence on the associations between physical activity and risk for cancer, and for… Expand
  • table 1
  • table 2
Review
2019
Review
2019
Spectrum of immune checkpoint inhibitors-induced endocrinopathies in cancer patients: a scoping review of case reports
BackgroundSince 2011 six immune checkpoint inhibitors (ICI) have been approved to treat patients with many advanced solid tumor… Expand
  • table 1
  • figure 1
  • table 2
  • table 4
  • figure 2
Review
2019
Review
2019
The role of SOX family members in solid tumours and metastasis.
Cancer is a heavy burden for humans across the world with high morbidity and mortality. Transcription factors including sex… Expand
Review
2019
Review
2019
Recent advances on anti-angiogenesis receptor tyrosine kinase inhibitors in cancer therapy
Angiogenesis has always been the topic of major scientific interest in the field of malignant tumors. Nowadays, targeting… Expand
  • figure 1
  • table 1
Review
2019
Review
2019
European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update.
CONTEXT The European Association of Urology Renal Cell Carcinoma (RCC) Guideline Panel has prepared evidence-based guidelines and… Expand
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Review
2018
Review
2018
From Tumor Immunology to Immunotherapy in Gastric and Esophageal Cancer
Esophageal and gastric cancers represent tumors with poor prognosis. Unfortunately, radiotherapy, chemotherapy, and targeted… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
Review
2018
Review
2018
Prognostic factors and prognostic models for renal cell carcinoma: a literature review
PurposeFollowing curative treatment for localised renal cell carcinoma (RCC), up to 30% of patients develop tumour recurrence… Expand
  • table 1
  • table 2
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE